Apalutamide Approved for Certain Prostate Cancers [News in Brief]

Along with its relative enzalutamide, antiandrogen prolongs metastasis-free survival in patients with few treatment options, studies show.

from Cancer via ola Kala on Inoreader http://ift.tt/2C7XBiq
via IFTTT